Titlebook: Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers; Multidisciplinary Ma Andrea Necchi,Philippe E. Spiess Book 2022 The

只看該作者 · 發(fā)表于 2025-3-24 02:28:55

Clinical Cases Debate: Neoadjuvant Versus Adjuvant Immunotherapy in Localized Renal Cell Carcinoma (nt therapies have been successfully downstaged and are thereby amenable to surgical intervention, this has not yet become the standard of care. In the adjuvant setting, despite FDA approval for sunitinib as well as potentially beneficial outcomes in selected cohorts, the use of adjuvant vascular end

只看該作者 · 發(fā)表于 2025-3-24 09:02:04

只看該作者 · 發(fā)表于 2025-3-24 12:34:02

Book 2022 an overview of biomarker use for patient selection across the early-stage GU malignancies.?Lastly, the book provides the reader with the most up-to-date data emerging from clinical trials involving immunotherapy in early-stage GU malignancies.?.Neoadjuvant Immunotherapy Treatment of Localized Genit

只看該作者 · 發(fā)表于 2025-3-24 17:16:43

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary CancersMultidisciplinary Ma

只看該作者 · 發(fā)表于 2025-3-24 22:17:10

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers978-3-030-80546-3

只看該作者 · 發(fā)表于 2025-3-24 23:35:09

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 01:25
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved